Tumor cells are reactive to smooth muscle actin (SMA), beta-catenin, lymphoid enhancer-binding factor 1 (LEF1), and cyclin D1, and it is associated with catenin beta-1 (CTNNB1) mutation [1]. This evidence concerns the gene CTNNB1 and neoplasm.